L. Mary Smith, Chief Development Officer at SpringWorks Therapeutics, Inc. (SWTX), sold 20,000 shares at $68.07 ($1.4M) on 2021-04-13, disclosed to the SEC on 2021-04-13.
Open-market sale of $1.4M SWTX by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $68.07 | 10,000 | $681K | 50.0% |
| 2 | $68.07 | 10,000 | $681K | 50.0% |
| Total | $68.07 avg | 20,000 | $1.4M | 100% |
| Filing → |
| SWTX | SELL | 2021-01-21 | $787K | — | Filing → |